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Height and risk of death among men and women:
aetiological implications of associations with
cardiorespiratory disease and cancer mortality
George Davey Smith, Carole Hart, Mark Upton, David Hole, Charles Gillis,
Graham Watt, Victor Hawthorne
Abstract
Objectives—Height is inversely associated
with cardiovascular disease mortality risk
and has shown variable associations with
cancer incidence and mortality. The
interpretation of findings from previous
studies has been constrained by data limi-
tations. Associations between height and
specific causes of death were investigated
in a large general population cohort of
men and women from the West of Scot-
land.
Design—Prospective observational study.
Setting—Renfrew and Paisley, in the West
of Scotland.
Subjects—7052 men and 8354 women aged
45–64 were recruited into a study in
Renfrew and Paisley, in the West of
Scotland, between 1972 and 1976. Detailed
assessments of cardiovascular disease risk
factors, morbidity and socioeconomic cir-
cumstances were made at baseline.
Main outcome measures—Deaths during
20 years of follow up classified into specific
causes.
Results—Over the follow up period 3347
men and 2638 women died. Height is
inversely associated with all cause, coron-
ary heart disease, stroke, and respiratory
disease mortality amongmen and women.
Adjustment for socioeconomic position
and cardiovascular risk factors had little
influence on these associations. Height is
strongly associated with forced expiratory
volume in one second (FEV1) and adjust-
ment for FEV1 considerably attenuated
the association between height and cardio-
respiratory mortality. Smoking related
cancer mortality is not associated with
height. The risk of deaths from cancer
unrelated to smoking tended to increase
with height, particularly for haematopoi-
etic, colorectal and prostate cancers.
Stomach cancer mortality was inversely
associated with height. Adjustment for
socioeconomic position had little influ-
ence on these associations.
Conclusion—Height serves partly as an
indicator of socioeconomic circumstances
and nutritional status in childhood and
this may underlie the inverse associations
between height and adulthood cardiores-
piratory mortality. Much of the associ-
ation between height and cardio-
respiratory mortality was accounted for
by lung function, which is also partly
determined by exposures acting in child-
hood. The inverse association between
height and stomach cancer mortality
probably reflects Helicobacter pylori
infection in childhood resulting in—or
being associated with—shorter height.
The positive associations between height
and several cancers unrelated to smoking
could reflect the influence of calorie
intake during childhood on the risk of
these cancers.
(J Epidemiol Community Health 2000;54:97–103)
The suggestion that stature is inversely related
to the risk of disease and mortality dates back
to the late 19th century.1 Insurance industry
data from the early decades of the 20th century
demonstrated that taller people, on average,
lived longer than shorter people.2 More re-
cently height has been investigated in relation
to coronary heart disease (CHD) risk, with
case-control and prospective studies identify-
ing inverse associations of height with the
extent of atherosclerosis,3 CHD incidence and
CHD mortality.4–7 A few studies have examined
other illnesses and have generally,7−10 but not
always,11 found inverse associations of height
with stroke. Inverse associations have been
found with respiratory disease risk,7 and incon-
sistent results with respect to cancer.7 10 12
Several mechanisms have been advanced to
account for the associations that have been
found. Firstly, height could serve as an indica-
tor of growth, nutrition and social environment
in earlier life. Poor fetal development13 and
poor growth during childhood14 have been
associated with increased cardiovascular dis-
ease risk in adulthood, as have indicators of
unfavourable social circumstances in
childhood.15–17 Conversely, a high calorie intake
in childhood may be related to an increased
risk of cancer in later life.18 Secondly, height is
related to social class in adulthood and thus
socially patterned exposures—including health
related behaviours, psychosocial influences,
environmental factors and the physiological
consequences of these—could account for the
observed disease associations. Thirdly, the
early stages of disease could lead to reductions
in height and this process could generate the
relation between height and mortality.7
The studies of height and mortality that had
been published to date have suVered from one
or more of a series of limitations: they tend to
be restricted to men; they have often used data
sources in which information on socioeco-
nomic position, cardiorespiratory disease risk
factors and health related behaviours have not
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been available; and they have generally involved
small samples, so cause-specific mortality
could not be examined. This study overcomes
these limitations and presents a detailed analy-
sis of height and mortality among a representa-
tive population sample of men and women
from the West of Scotland.
Methods
The Renfrew/Paisley general population study
was carried out between 1972 and 1976: the
sampling frame was residents of the towns of
Renfrew and Paisley aged 45–64 years, and a
near 80% response rate was achieved. Full
details of the study methodology have been
reported previously.19 A questionnaire was
completed by each participant and this was
checked when the participant attended a
screening examination. The questionnaire re-
corded smoking habit, occupation, respiratory
and cardiovascular symptoms. Social class was
determined by regular occupation, according
to the Registrar General’s classification.20 In
the case of retired people, the last full time
occupation was taken. For housewives, hus-
bands’ or fathers’ occupations were used.
Participants were classified as non-manual if
they were in social classes I, II or IIIN and
manual if in social classes IIIM, IV or V. Blood
pressure, height (to the nearest centimetre) and
weight were measured and an electrocardio-
gram was recorded at the screening examina-
tion. A non-fasting blood sample was also
taken to measure plasma cholesterol concen-
tration. Forced expiratory volume in one
second (FEV1) was measured and is treated
both as a simple continuous variable and as an
“FEV score”, expressed as a percentage of the
expected FEV1 for age and height, calculated
from the subset of healthy never smoking
participants.21
The six lead electrocardiogram (leads I, II,
III, AVr, AVl and AVf) was taken with the sub-
ject sitting. Criteria for myocardial ischaemia
on ECG were based on the Minnesota coding
scheme. Any of the following codes were
considered evidence of ischaemia, encompass-
ing diagnoses of definite myocardial infarction,
myocardial ischaemia and left bundle branch
block: 1.1–1.3, 4.1–4.4, 5.1–5.3, 7.1. Angina
was considered present if the definite or possi-
ble criteria of the Rose Angina Questionnaire
were met.22 Bronchitis was classified according
to responses to the Medical Research Council
questionnaire.23
The home address at the time of screening
was retrospectively postcoded, enabling an
area-based deprivation category at the time of
the 1981 census to be ascertained.24 Depriva-
tion category varies from 1 (least deprived) to 7
(most deprived). Deprivation category and
individual social class are related independ-
ently to mortality in the study population.25 A
total of 7052 men and 8354 women were
included in the study. This diVers slightly from
numbers given in previous publications (7058
men and 8353 women) as 13 miscodings of sex
and five people who attended twice were
recently discovered.
Height data were missing for three men and
10 women, who were excluded from all analy-
ses. The analyses were therefore performed on
7049 men and 8344 women. For seven partici-
pants addresses could not be postcoded and
assigned a deprivation category and 423
participants had given insuYcient information
on occupation to assign a social class. Dummy
variables were created for these participants for
inclusion in multivariable analyses. Partici-
pants were flagged at the National Health
Service Central Register in Edinburgh and
notification of deaths have been received for a
20 year follow up period. Cause of deaths were
coded to ICD9.26 We classified the following as
smoking related cancers; lip (ICD-9 140);
tongue (141); mouth and pharynx (143–9);
oesophagus (150); pancreas (157); respiratory
tract (160–163) and urinary tract (188–189).18
As height was measured to the nearest centi-
metre the approximate quintile groups showed
some variation in size. Analyses were con-
ducted by height quintile and also according to
a 10 centimetre lower height, assuming a linear
relation between height and outcome. Age
adjusted means for continuous variables were
calculated using PROC GLM of the SAS
system. Categorical variables were age stand-
ardised by the direct method, using the male
and female study populations as the standard.
Age adjusted mortality rates were calculated
using a person years at risk based lifetable
approach and age standardisation was by the
direct method. Trend tests were obtained
through proportional hazards regression using
PROC PHREG. Proportional hazards
regression analyses of the whole cohort were
stratified by sex within the PROC PHREG
routine in SAS; except where sex specific
analyses have been reported. The exponenti-
ated proportional hazards regression coeY-
cients are referred to as relative rates.
Results
For men the mean height was 169.6 cm
(standard deviation 6.8; first centile 154 cm
and 99th centile 185). For women the mean
height was 157.7 cm (standard deviation 6.1;
first centile 143 cm and 99th centile 172). The
characteristics of the population according to
height are presented in table 1. For both men
and women greater height was associated with
younger age at screening, therefore data on all
other factors were age adjusted. Taller partici-
pants were less likely to come from social class
IV and V, less likely to live in deprived areas,
less likely to report angina or bronchitis on a
screening questionnaire, more likely to be
ex-smokers, and less likely to have ischaemia
detected on an ECG than shorter participants.
Taller participants had higher FEV1 than
shorter participants and for women, but not
men, this was also true for FEV1 score. For
men, but not women, taller participants had
slightly higher blood pressure and were less
likely to be current cigarette smokers than
shorter participants. For women, but not men,
taller participants had lower plasma cholesterol
concentrations and lower body mass index
than shorter participants.
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Table 2 shows the mortality rates and relative
rates associated with 10 cm lower height. All
cause, coronary heart disease, stroke and respi-
ratory disease mortality are inversely related to
height. For both sexes respiratory disease is the
cause of death most strongly associated with
height. For men stroke is more strongly associ-
ated with height than coronary heart disease,
while there is little diVerence for women.
Adjustment for socioeconomic, behavioural
and physiological risk factors had little influ-
ence on the association between height and
mortality. In these adjustments the FEV1 score
was used as the measure of lung function. Raw
FEV1 is strongly correlated with height (r=0.38
for men and r=0.37 for women), and several
studies have suggested that lung function
accounts for the association of height with
cardiovascular mortality and morbidity.4 In-
cluding raw FEV1 rather than FEV1 score
among the factors adjusted for resulted in con-
siderable attenuation of the associations be-
tween height and cardiorespiratory mortality,
with relative rates for 10 cm lower height in
men being 1.02 (95% CI 0.93, 1.11) for
coronary heart disease; 1.19 (0.99, 1.42) for
stroke and 0.91 (0.75, 1.09) for respiratory
disease mortality in the fully adjusted models.
For women the equivalent relative rates were
1.08 (0.95, 1.22) for coronary heart disease;
1.10 (0.92, 1.31) for stroke and 1.28 (0.99,
1.65) for respiratory disease mortality. We also
examined the associations between raw FEV1
and cardiorespiratory mortality (table 3). The
strong associations found were little influenced
by adjustment for height.
Smoking related cancer mortality is not
associated with height (table 2). Mortality from
smoking unrelated cancers tended to be
positively associated with height, although
there was considerable heterogeneity within
this category. Table 4 shows that stomach can-
cer is inversely associated with height. Mor-
tality from haematopoietic cancers, colorectal
cancer and prostate cancer tended to be
directly related to height, while breast cancer
was unrelated to height. The association
between height and haematopoietic cancer was
largely limited to lymphoma (ICD 200–203),
with an age adjusted combined relative rate of
0.44 (0.29, 0.65) for 10 cm lower height; for
leukaemia (ICD 204–208) the equivalent rela-
tive rate was 0.89 (0.46, 1.72). There were no
significant interactions between height and sex
in any of these analyses.
For all cause and cardiorespiratory disease
mortality, associations were analysed separately
for the first 10 years and second 10 years of
follow up. The only finding consistent between
sexes was that the association between height
and respiratory disease mortality was consider-
ably stronger over the initial 10 year follow up
period than the later period. For men the rela-
tive rate for 10 cm lower height over the first 10
years of follow up was 1.75 (1.32, 2.33); over
the second 10 years this was 1.28 (1.03, 1.61).
For women the equivalent relative rates were
2.20 (1.51, 3.20) and 1.58 (1.21, 2.07).
Discussion
Height in this large general population study is
inversely associated with all cause mortality
among men and women over a 20 year follow
up period. The strength and direction of the
association between height and mortality varies
Table 1 Risk factors according to height quintiles (age adjusted means or proportions)
Men
Height quintile
Trend*<163 cm 164–167 cm 168–170 cm 171–174 cm >175 cm
Number 1281 1359 1305 1480 1624
Mean age at screening (y)† 55.2 54.7 54.2 53.8 53.1 p=0.0001
Mean diastolic BP (mm Hg) 85.8 85.5 86.4 85.5 86.9 p=0.019
Mean cholesterol (mmol/l) 5.87 5.85 5.87 5.85 5.87 p=0.60
Mean body mass index (kg/m2) 25.9 25.9 26.0 25.8 25.8 p=0.29
Mean FEV1 (l) 2.18 2.37 2.49 2.63 2.82 p=0.0001
Mean adjusted FEV1 (%) 88.3 88.2 88.2 89.4 88.9 p=0.10
% never smoked 17.5 17.1 16.5 16.4 16.4 p=0.35
% current cigarette smokers 61.4 58.2 54.2 55.9 54.5 p=0.0003
% ex smokers 19.5 22.2 27.0 25.7 27.6 p=0.0001
% deprivation category 5–7 68.2 62.6 59.6 53.1 49.7 p=0.0001
% social class IV and V 37.7 31.2 28.6 25.6 22.4 p=0.0001
% angina (definite and possible) 21.6 18.9 17.5 15.2 15.3 p=0.0001
% bronchitis 7.6 6.4 6.4 4.4 4.5 p=0.0001
% ECG ischaemia 12.4 10.5 10.1 9.3 10.2 p=0.036
Height quintile
Women <152 cm 153–155 cm 156–158 cm 159–162 cm >163 cm Trend*
Number 1638 1378 1606 2003 1719
Mean age at screening (y)† 55.9 54.9 54.5 53.9 53.0 p=0.0001
Mean diastolic BP (mm Hg) 85.4 85.6 84.8 84.9 85.2 p=0.53
Mean cholesterol (mmol/l) 6.49 6.45 6.42 6.42 6.35 p=0.001
Mean body mass index (kg/m2) 26.5 26.2 25.8 25.8 25.0 p=0.0001
Mean FEV1 (l) 1.55 1.66 1.78 1.84 2.00 p=0.0001
Mean adjusted FEV1 (%) 90.3 90.9 93.6 92.8 94.4 p=0.0001
% never smoked 45.8 46.6 46.2 44.9 45.3 p=0.11
% current cigarette smokers 48.5 47.7 45.6 47.2 45.0 p=0.29
% ex smokers 5.5 5.7 8.2 7.8 9.6 p=0.0001
% deprivation category 5–7 66.9 60.6 58.5 56.7 50.9 p=0.0001
% social class IV and V 48.3 42.3 39.8 35.0 29.2 p=0.0001
% angina (definite and possible) 20.9 17.0 17.2 15.9 13.9 p=0.0001
% bronchitis 6.5 3.8 4.2 3.1 3.2 p=0.0001
% ECG ischaemia 10.8 11.5 9.6 9.7 8.6 p=0.021
*Using height as a continuous variable. †Not age adjusted.
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between broad cause of death groups, however.
Among both men and women respiratory
disease mortality is most strongly associated
with height, with inverse associations also being
seen for cardiovascular disease mortality.
Among men the association is stronger with
respect to stroke than coronary heart disease,
although among women there is little diVer-
ence between these associations. Stomach can-
cer mortality is inversely associated with
height, while smoking related cancer mortality
is not associated with height. Mortality from
smoking unrelated cancers, with the exception
of stomach cancer, tends to be positively asso-
ciated with height: taller people experience
higher mortality rates.
GENERAL EXPLANATIONS OF HEIGHT-MORTALITY
ASSOCIATIONS
Two possible general explanations of inverse
associations between height and mortality need
to be considered. Firstly, height is associated
with socioeconomic position: people in better
socioeconomic circumstances are, on average,
taller. This is shown in our own data with
respect to occupational social class and area-
based deprivation measures. Confounding by
socioeconomic position would, then, be ex-
pected to produce inverse associations between
height and mortality. If this explanation were
the case then these associations should be seen
for all causes of death that show strong
Table 2 Age adjusted 20 year mortality (per 10 000 person years) in the Renfrew/Paisley Study by height quintile
Men (n=7049)
Height quintile
RR* (95% CI) RR† (95% CI)<163 cm 164–167 cm 168–170 cm 171–174 cm >175 cm
All cause
Number of deaths 685 704 600 661 697
Mortality rate 257.5 255.5 234.7 232.5 233.1 1.13 (1.07,1.19) 1.10‡ (1.04,1.16)
CHD
Number of deaths 278 248 238 251 266
Mortality rate 132.6 115.1 111.6 105.3 107.5 1.14 (1.05,1.24) 1.12‡ (1.03,1.22)
Stroke
Number of deaths 74 64 57 59 48
Mortality rate 43.3 38.5 33.0 32.9 25.6 1.32 (1.11,1.57) 1.30‡ (1.10,1.55)
Respiratory disease
Number of deaths 69 72 51 40 48
Mortality rate 36.9 42.0 30.9 22.6 23.6 1.45 (1.21,1.72) 1.35§ (1.12,1.61)
Smoking related cancer
Number of deaths 115 129 109 131 148
Mortality rate 61.5 63.0 55.0 59.6 64.1 1.03 (0.91,1.15) 0.96§ (0.86,1.09)
Smoking unrelated cancer
Number of deaths 60 81 64 70 90
Mortality rate 35.2 43.7 35.2 35.9 40.5 0.92 (0.79,1.07) 0.88¶ (0.75,1.03)
Height quintile
Women (n=8344) <152 cm 153–155 cm 156–158 cm 159–162 cm >163 cm RR* (95% CI) RR† (95% CI)
All cause
Number of deaths 632 473 515 598 420
Mortality rate 177.6 168.0 160.7 156.9 137.4 1.19 (1.11,1.26) 1.16‡ (1.08,1.23)
CHD
Number of deaths 208 149 130 179 105
Mortality rate 69.0 61.2 48.3 54.8 40.3 1.29 (1.15,1.45) 1.22‡ (1.08,1.37)
Stroke
Number of deaths 101 78 75 75 57
Mortality rate 35.2 34.9 30.5 27.7 25.9 1.23 (1.04,1.45) 1.20‡ (1.02,1.43)
Respiratory disease
Number of deaths 54 43 36 32 23
Mortality rate 19.1 19.6 15.2 10.5 9.6 1.75 (1.40,2.18) 1.77§ (1.38,2.27)
Smoking related cancer
Number of deaths 62 35 55 80 62
Mortality rate 22.8 15.0 20.7 24.2 22.6 0.98 (0.81,1.18) 1.01§ (0.83,1.23)
Smoking unrelated cancer
Number of deaths 94 94 123 136 107
Mortality rate 32.5 40.3 44.5 39.4 35.3 0.93 (0.81,1.07) 0.89¶ (0.77,1.02)
*Age adjusted relative rate for 10 cm lower height. †Fully adjusted relative rate for 10 cm lower height. ‡Adjusted for social class, deprivation category, smoking,
diastolic blood pressure, cholesterol, body mass index, and FEV score. §Adjusted for social class, deprivation category, smoking, body mass index and FEV score.
¶Adjusted for social class, deprivation category, body mass index and FEV score.
Table 3 Age adjusted relative rates (95% CI) for a one standard deviation lower FEV1,
with and without additional height adjustment
CHD Stroke Respiratory disease
Men
age* 1.28 (1.21, 1.36) 1.38 (1.22, 1.55) 3.55 (3.14, 4.01)
age/height† 1.27 (1.20, 1.36) 1.33 (1.17, 1.51) 3.60 (3.18, 4.07)
Women
age* 1.42 (1.31, 1.53) 1.34 (1.20, 1.49) 2.77 (2.39, 3.20)
age/height† 1.40 (1.29, 1.51) 1.32 (1.17, 1.48) 2.71 (2.32, 3.17)
*Adjusted for age. †Adjusted for age and height.
Table 4 Relative rates (95% CI) for 10 cm lower height for cancers unrelated to smoking
Number Male RR* Female RR* Combined RR* Combined RR†
All smoking unrelated cancers 919 0.92 (0.79,1.07) 0.93 (0.81,1.07) 0.92 (0.83,1.02) 0.89 (0.80,0.99)
Stomach (ICD 151) 103 1.43 (0.95,2.14) 1.54 (0.98,2.41) 1.47 (1.09,1.99) 1.33 (0.97,1.80)
Colorectal (ICD 153-4) 201 0.71 (0.53,0.96) 0.80 (0.58,1.10) 0.75 (0.60,0.94) 0.70 (0.56,0.88)
Breast (ICD 174) 147 — 1.13 (0.86,1.48) — —
Prostate (ICD 185) 59 0.77 (0.53,1.14) — — —
Haematopoietic (ICD 200-8) 79 0.63 (0.39,1.03) 0.45 (0.28,0.73) 0.53 (0.38,0.75) 0.52 (0.36,0.73)
Other (remainder) 330 1.14 (0.87,1.49) 0.90 (0.72,1.13) 0.99 (0.83,1.18) 0.98 (0.82,1.17)
*Adjusted for age. †Adjusted for age, social class and deprivation category.
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socioeconomic gradients. Smoking related can-
cers demonstrate some of the strongest associa-
tions with adverse socioeconomic circum-
stances,27 however they are not related to
height. This argues against socioeconomic
confounding as being key to the height-
mortality associations, as does the robustness
of the associations to adjustment for social class
and area-based deprivation scores in the
present data.
Secondly, early stages of disease could lead
to a loss of height.7 This could either be real,
because of disc space compression, or appar-
ent, because of inability to stretch during
height measurement. In either case the lower
measured height, on average, of the sick would
produce inverse height-mortality associations.7
This has been explored in a previous study by
analysing mortality during earlier and later
periods of mortality follow up. Such reverse
causation should produce stronger inverse
associations in the earlier period of follow up,
because as people with pre-existing disease die
and are removed from the cohort they contrib-
ute less and less to the height-mortality
associations. In an earlier study such attenua-
tion over time was seen for both respiratory
disease and coronary heart disease mortality.7
In the present data such attenuation was only
convincingly demonstrated for respiratory dis-
ease mortality. This suggests that such reverse
causality is mainly an issue with respect to res-
piratory disease, a finding that is biologically
plausible.
HEIGHT AND CAUSE SPECIFIC MORTALITY
There are several factors, indexed by short
stature, which could be responsible for the
associations between height and mortality.
Adult height is influenced by fetal development
(indexed by birth weight), and growth during
pregnancy and adolescence.28 Factors that
result in reduced birth weights—such as poor
maternal nutrition and smoking—may, there-
fore, influence adult height. Genetic factors are
also clearly of importance, although these
could not be investigated in this study.
Nutrition in infancy and adolescence are
reflected in final adult height. Adverse social
circumstances during childhood are also re-
lated to shorter stature in adulthood.28 It is
notable that in this study height is inversely
associated with risk of stomach cancer, stroke,
CHD and respiratory disease mortality. In a
separate Scottish cohort we have demonstrated
that adverse social circumstances in
childhood—indexed by paternal occupational
social class—are associated with high rates of
mortality from these causes.17
Early life determinants of stomach cancer
mortality are implicated by ecological correla-
tions between present day stomach cancer rates
and indicators of adverse social circumstances,
at the time when the cohorts who are currently
developing stomach cancer were children.29
Helicobacter pylori infection is generally ac-
quired in childhood and this has been shown to
be related to overcrowded housing and poor
sanitary environments.30 Helicobacter pylori in-
fection persisting from childhood is an impor-
tant cause of stomach cancer31 and is also asso-
ciated with poorer growth and shorter attained
height.32 33 Thus the inverse association be-
tween height and stomach cancer mortality,
also seen in a previous study,34 could reflect
chronic Helicobacter pylori infection.
The higher stroke, CHD and respiratory dis-
ease mortality of people who experienced
worse social circumstances in childhood is seen
after socioeconomic position and cardiorespi-
ratory risk factors in adulthood are taken into
account.17 Similarly, in the present data adjust-
ing for indicators of adulthood socioeconomic
position, blood pressure, smoking, body mass
index, cholesterol and FEV1 score had little
eVect on the inverse association between height
and cardiovascular mortality; a more substan-
tial attenuation of the association between
height and respiratory disease mortality was
seen, although a substantial residual eVect
remained. Adjustment for raw FEV1 greatly
attenuated the associations between height and
cardiorespiratory mortality, however. There
has been considerable debate in the literature
as to the appropriateness of adjusting for raw
lung function measures when assessing the
association between height and mortality.4 35–39
Height is strongly correlated with raw FEV1, in
part simply because taller people have larger
lungs. Thus adjusting for raw FEV1 is adjusting
for a proxy for height itself. In the present data,
as in an earlier study,35 it is noticeable that
adjusting height-mortality associations for raw
FEV1 greatly attenuates the relative rates, while
adjusting raw FEV1-mortality associations for
height has virtually no eVect. If the problem
was simply one of collinearity it should
influence both sets of adjustments. FEV1 score
is an index of lung health, while raw FEV1 is an
index of both lung health and lung capacity. In
this simplified scheme, lung health includes a
component attributable to airways geometry
that is not proportional to height.40 Raw FEV1
is thus influenced both by body dimensions
and by exposures acting across the lifecourse
that influence lung function in adulthood.
These factors include fetal development, child-
hood chest illnesses, smoking and occupational
exposures in adulthood.41 Adjustment for raw
FEV1 may, therefore, be equivalent to adjusting
for a sensitive index of accumulating exposures
acting across the lifecourse.42
The associations between adult height and
cancer have been inconsistent across cancer
KEY POINTS
x Greater height is associated with reduced
risk of coronary heart disease, stroke and
respiratory death.
x Lung function is an important mediator
of the association between height and
cardiorespiratory mortality.
x Greater height is associated with in-
creased risk of several cancers unrelated
to smoking.
x The association between height and can-
cer may reflect the influence of calorie
intake during childhood.
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sites, for cancer incidence or cancer mortality
and between studies,7 10 12 43 44 although gener-
ally it is cancers unrelated to smoking that are
found to be positively associated with
height.12 45 The positive associations we found
between height and prostate cancer, colorectal
cancer and lymphoma have been seen in most,
but not all, previous studies.7 11 43 44 In most
previous studies height has been positively
associated with breast cancer risk,46 although
we did not find this. The interpretation of posi-
tive height-cancer associations has focused on
caloric intake in early life as a determinant of
both height and later cancer risk,12 45 a sugges-
tion that is strengthened by the recent demon-
stration of a direct association between energy
intake in childhood and later risk of non-
smoking related cancers.18 Animal experiments
have repeatedly demonstrated that caloric
restriction from early age reduces the risk of
cancer in later life.47 Recent reports of positive
associations between insulin-like growth
factor-I levels and prostate, colon and breast
cancer provide a possible mechanism for the
above associations.48–50 Calorie restricted diets
that decrease cancer risk in animals also
decrease IGF-I levels.51 Height may serve as an
indicator of IGF-I levels during growth and
developmental phases,52 which has been pro-
posed as the period during which IGF-I levels
act to increase cancer risk in later life.50
Height may reflect other early life exposures,
such as the absence or delay of childhood
infections. Large sibships, which are associated
with shorter height, have been associated with a
reduced risk of Hodgkin’s disease.53 In another
study in the West of Scotland17 we have found
an inverse association between number of
siblings and risk of mortality from lymphoma
(Davey Smith and Hart, unpublished observa-
tions).
Long term secular trends in height have been
associated with changing mortality rates in
Britain and elsewhere.54 In Britain for people
born during the second quarter of the 19th
century height decreased with year of birth,
then increased for people born after the
mid-century.54 This pattern is strikingly similar
to mortality trends. All cause mortality showed
no improvement (and in some places even
increased) over the second quarter of the cen-
tury, and then from around 1850 mortality
reductions were seen in a cohort specific man-
ner, first for children, then for young adults and
then for older adults.55 56 Both the height and
mortality data suggest that childhood circum-
stances started to improve around the middle
of the 19th century and that people who were
young children during this period took with
them, as their cohort aged, a reduced mortality
risk. Our data on the cause specific associations
of mortality and height suggest that a similar
co-dependency of height and mortality may be
occurring presently. Height in Britain has con-
tinued to increase throughout the second half
of the 20th century.57 The causes of death that
are inversely associated with height are those
that tend to be decreasing, such as stroke,
stomach cancer and respiratory disease mor-
tality. The causes of death that show a positive
association with height are those showing less
favourable trends, such as prostate cancer,
lymphoma and colorectal cancer. The factors
that underlie the secular trend of increasing
height in the population may also be influenc-
ing cause specific mortality rates. Plausible
underlying factors include increasing net en-
ergy balance (that is, energy intake minus that
expended in physical activity, in keeping warm,
etc) intake in childhood, and decreases and
delays in infection in childhood.58
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